MedTrace Logo

Digital Storytelling and Mother's Knowledge and Attitudes Towards Newborn Screning

NCT07450742 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2026-03-05

No results posted yet for this study

Summary

The aim of this study is to examine the effect of health education supported by digital storytelling on mothers' knowledge and attitudes towards newborn screening. It is a single-blind, controlled-group, randomized controlled experimental study. The hypotheses of the study are:

H0: Health education supported by digital storytelling has no effect on mothers' knowledge and attitudes towards newborn screening.

H1: Health education supported by digital storytelling has an effect on mothers' knowledge and attitudes towards newborn screening. Participants will:

* Be 28-32 weeks pregnant
* Be able to speak and understand Turkish
* Use a smartphone with internet access

Conditions

  • Digital Storytelling

Interventions

BEHAVIORAL

HEALTH EDUCATION SUPPORTED BY DIGITAL STORYTELLING

The health education program, supported by digital storytelling, to be applied to the experimental group is a four-week program. Sessions will be held face-to-face at family health centers one week apart. Telephone calls will be made during the first week to remind participants or inform them about their appointments. Four stories were created for the digital storytelling-supported health education program for the experimental group, using the website www.storyjumper.com. The first story covers the purpose and scope of newborn screenings, the second the testing process and possible outcomes, the third the definition of diseases and treatment options, and the fourth the parents' right to information and responsibility to participate in screenings.

Sponsors & Collaborators

  • Kirsehir Ahi Evran Universitesi

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2026-06-30
Completion
2026-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07450742 on ClinicalTrials.gov